Arkolith/Insider Trading/AVIR/Form 4

Lucidi Bruno

DirectorAtea Pharmaceuticals, Inc. (AVIR) · full profile →Form 4 · filed Jun 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Option exercise(M)30K—$0113K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Grant(A)41K—$041K
Jun 20, 2025Grant(A)30K—$030K
Jun 20, 2025Option exercise(M)30K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-089604) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML